Literature DB >> 23707422

B-regulatory cells in autoimmunity and immune mediated inflammation.

Zahava Vadasz1, Tharwat Haj, Aharon Kessel, Elias Toubi.   

Abstract

B cells are a source of inhibitory cytokines such as IL-10 and TGF-β. The ability of being B-regulatory cells (B-regs) was shown to be driven by many stimulatory factors such as toll-like receptors, CD40-ligand and others. However, the characterization of B-regs is still underway. B-regs express high levels of CD25, CD86, IL-10 and TGF-β. In addition, we propose that semaphorin3A is a regulatory molecule and therefore can serve as one of the additional markers for B-regs. This subset of B cells was able to suppress Th1 proliferation, thus contributing to the maintenance of self-tolerance. Finally, the potentiation of B-reg function should become the aim of many immunomodulatory drugs, contributing to a better control of autoimmune diseases.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707422     DOI: 10.1016/j.febslet.2013.05.023

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  30 in total

Review 1.  The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Maria Clorinda Mazzarino
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 2.  Current perspectives on the link between neuroinflammation and neurogenesis.

Authors:  Brian Wang; Kunlin Jin
Journal:  Metab Brain Dis       Date:  2014-03-13       Impact factor: 3.584

3.  Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistance.

Authors:  Lan Wu; Vrajesh V Parekh; Joseph Hsiao; Daisuke Kitamura; Luc Van Kaer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

4.  Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis.

Authors:  Chen Xing; Ning Ma; He Xiao; Xiaoqian Wang; Mingke Zheng; Gencheng Han; Guojiang Chen; Chunmei Hou; Beifen Shen; Yan Li; Renxi Wang
Journal:  J Leukoc Biol       Date:  2014-12-16       Impact factor: 4.962

5.  Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.

Authors:  Y Peng; X Chen; Q Liu; X Zhang; K Huang; L Liu; H Li; M Zhou; F Huang; Z Fan; J Sun; Q Liu; M Ke; X Li; Q Zhang; A P Xiang
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

6.  Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.

Authors:  Timothy W Phares; Krista D DiSano; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

7.  Clostridium difficile recurrence is characterized by pro-inflammatory peripheral blood mononuclear cell (PBMC) phenotype.

Authors:  Mary B Yacyshyn; Tara N Reddy; Lauren R Plageman; Jiang Wu; Amy R Hollar; Bruce R Yacyshyn
Journal:  J Med Microbiol       Date:  2014-07-07       Impact factor: 2.472

Review 8.  Regulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis.

Authors:  Damian Maseda; Rachel H Bonami; Leslie J Crofford
Journal:  Expert Rev Clin Immunol       Date:  2014-04-16       Impact factor: 4.473

Review 9.  Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.

Authors:  Xiao-Rong Xu; Chang-Qin Liu; Bai-Sui Feng; Zhan-Ju Liu
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

10.  IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction.

Authors:  Lan Wu; Rajeev Dalal; Connie D Cao; J Luke Postoak; Guan Yang; Qinkun Zhang; Zhizhang Wang; Hind Lal; Luc Van Kaer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.